SMARCD3
Basic information
Region (hg38): 7:151238764-151277896
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMARCD3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 0 | 0 |
Variants in SMARCD3
This is a list of pathogenic ClinVar variants found in the SMARCD3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-151239464-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
7-151239479-C-T | not specified | Uncertain significance (Jun 29, 2022) | ||
7-151239482-C-A | not specified | Uncertain significance (Nov 09, 2024) | ||
7-151239647-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
7-151239667-C-G | not specified | Uncertain significance (Aug 30, 2022) | ||
7-151239692-G-T | not specified | Uncertain significance (May 09, 2024) | ||
7-151240126-C-T | not specified | Uncertain significance (Jul 09, 2024) | ||
7-151240141-G-C | not specified | Uncertain significance (Apr 12, 2024) | ||
7-151240444-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
7-151240479-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
7-151240494-G-A | not specified | Uncertain significance (Jul 14, 2024) | ||
7-151240506-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
7-151241902-G-A | not specified | Uncertain significance (Jan 19, 2022) | ||
7-151242531-C-T | not specified | Uncertain significance (Jul 11, 2023) | ||
7-151242597-G-A | not specified | Uncertain significance (Nov 08, 2021) | ||
7-151242809-A-G | not specified | Uncertain significance (May 24, 2023) | ||
7-151243671-G-C | not specified | Uncertain significance (Oct 06, 2024) | ||
7-151243699-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
7-151245523-G-A | not specified | Uncertain significance (Jul 07, 2022) | ||
7-151245566-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
7-151245598-A-T | Uncertain significance (May 01, 2022) | |||
7-151248493-G-A | Uncertain significance (May 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SMARCD3 | protein_coding | protein_coding | ENST00000262188 | 13 | 39133 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.405 | 0.595 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.58 | 139 | 255 | 0.546 | 0.0000158 | 3166 |
Missense in Polyphen | 46 | 90.279 | 0.50953 | 949 | ||
Synonymous | -0.404 | 106 | 101 | 1.05 | 0.00000574 | 946 |
Loss of Function | 3.43 | 5 | 22.6 | 0.222 | 0.00000100 | 284 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000816 | 0.000816 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.000816 | 0.000816 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Stimulates nuclear receptor mediated transcription. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron- specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). {ECO:0000250|UniProtKB:Q6P9Z1, ECO:0000269|PubMed:29374058, ECO:0000269|PubMed:8804307, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.;
- Pathway
- Thermogenesis - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Androgen Receptor Network in Prostate Cancer;Tumor suppressor activity of SMARCB1;Gene expression (Transcription);RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Generic Transcription Pathway;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);Metabolism of lipids;RNA Polymerase II Transcription;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism;Validated transcriptional targets of TAp63 isoforms;Chromatin organization;Transcriptional regulation by RUNX1;LKB1 signaling events
(Consensus)
Recessive Scores
- pRec
- 0.186
Intolerance Scores
- loftool
- 0.555
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.36
Haploinsufficiency Scores
- pHI
- 0.950
- hipred
- Y
- hipred_score
- 0.829
- ghis
- 0.638
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.888
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Smarcd3
- Phenotype
Zebrafish Information Network
- Gene name
- smarcd3b
- Affected structure
- heart
- Phenotype tag
- abnormal
- Phenotype quality
- inverted
Gene ontology
- Biological process
- positive regulation of neuroblast proliferation;secondary heart field specification;cardiac right ventricle formation;neural retina development;nucleosome disassembly;chromatin remodeling;transcription, DNA-templated;regulation of transcription by RNA polymerase II;positive regulation of G2/M transition of mitotic cell cycle;regulation of lipid metabolic process;muscle cell differentiation;regulation of protein binding;positive regulation of transcription, DNA-templated;positive regulation of smooth muscle cell differentiation
- Cellular component
- nuclear chromatin;nucleus;nucleoplasm;SWI/SNF complex;npBAF complex;nBAF complex
- Molecular function
- chromatin binding;transcription coactivator activity;signaling receptor binding;transcription factor binding;nuclear hormone receptor binding